Navigation Links
Kamar Aulakh Joins Velos, Inc. as Chief Operating Officer
Date:3/18/2010

FREMONT, Calif., March 18 /PRNewswire/ -- Velos, Inc., the recognized leader and trusted resource for clinical trials management information systems, announced today that Kamar Aulakh has joined the company to serve as Chief Operating Officer. Aulakh comes with an extensive background as engineer, entrepreneur and business leader in technology and healthcare. In his role as COO, he will oversee all operating teams to drive continued expansion and market leadership.

"We are very pleased to welcome a person of this caliber on board," said John S. McIlwain, President and CEO of Velos. "We're gratified to have the talents and accomplishments of Kamar Aulakh focused in Velos on a variety of levels. In its current stage of evolution Velos needs, and will benefit from, his considerable expertise and business acumen. He is already addressing issues of organizational readiness for growth and structural improvements throughout all our operations."

Aulakh has substantial corporate experience. He was President and CEO of Quark, Inc., a leading developer of software solutions for professional publishers worldwide. During his tenure, he grew Quark to a 1900-employee organization positioned to take advantage of the next major shift in publishing, that of end-to-end digital workflows and multi-channel output. He established and managed technology development centers in the U.S., Germany, Singapore and India. Prior to that, he held various senior management and technical positions with Fortune 500 Companies working in telecommunications, energy and healthcare sectors.

As entrepreneur, Aulakh founded companies in the U.S., Switzerland and India. These include: NexOkO, providing customers with an Internet-based subscription service for managing their digital content and communications; PioneeringMed, employing innovative techniques to automate and improve healthcare processes; and BayaTree, a forward-thinking business consulting company with a focus on project management, business processes, outsourcing and technology enabled services.

"Velos customers receive more than 40% of NIH extramural grants and 50% are among the 100 biggest such recipients. These are the largest market shares in our product class. We continue to expand both in the U.S. and globally," said McIlwain. "Kamar Aulakh's proven know-how in all facets of software and Internet operations will be very valuable as we go forward. We're proud that he has decided to accept the challenge with us."

About Velos

Velos, Inc. is the trusted clinical trial management resource for investigators, sponsors and academic leaders throughout the U.S. Its customers include 21 of the top 25 academic medical centers and research institutions. Among the 100 largest recipients of NIH clinical research funding, Velos customers receive over 50% of NIH extramural grants. Velos eResearch is deployed for clinical research in all parts of the healthcare enterprise and supports a broad diversity of clinical departments and functional needs. The system fundamentally improves the way data is collected, organized and shared. A pure Internet technology platform, Velos eResearch harnesses advanced powers of the Internet to enable research sites, sponsors, and patients to collaborate in a secure, integrated system platform. System users are freed of redundant data entry and related time delays associated with most clinical research today. With emphasis on workflow, Velos integrates the clinical, administrative and financial information needs of research management. Velos eResearch has been certified as caBIG® Bronze Compatible by the caBIG® Bronze Compatibility Certification Program, created by the National Cancer Institute Center for Bioinformatics, in cooperation with the NCI Technology Transfer Branch. Founded in 1996, Velos is privately held with headquarters in Fremont, California. For more information, visit www.velos.com

This press release may contain forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those set forth in the forward-looking statements.

SOURCE Velos, Inc.

Back to top

RELATED LINKS
http://www.velos.com

'/>"/>

SOURCE Velos, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. Nationally Known Interventional Neuroradiologist John Pile-Spellman, M.D., Joins Neurological Surgery, P.C.
2. ClinAudits Joins Bioanalytical Quality Standards Initiative (BQSI) Expert Working Group
3. Dr. Young-Ho Oh Joins Harrington Physician Services; Orthopedic Surgeon Will Enhance Hospitals Surgery Capabilities
4. Netball Australia Joins Forces with DealsDirect.com.au, Australia's Leading Online Department Store
5. Peyton Marshall Joins LeveragePoint Innovations Board
6. Walter Chesley Joins Blue Cross Board of Trustees
7. North American Spine Joins Governor Arnold Schwarzenegger at 2010 ICA Symposium
8. Suunto Joins ANT+ Interoperable Ecosystem
9. Alan Henry, M.D. Joins MedSolutions as Chief Medical Officer of Premerus
10. Barcode Joins the Battle of the Bulge in New iPhone App
11. DNC Chairman Kaine Joins President Obama in Calling on Congress to Finish the Job, Pass Health Insurance Reform
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... December 08, 2016 , ... The ... the Undersea and Hyperbaric Medical Society (UHMS), the leading authority in hyperbaric medicine. ... safety. Only a few hospitals and facilities have earned this distinction. This is ...
(Date:12/8/2016)... ... December 08, 2016 , ... Russ ... announced the first national #QuackGivesBack campaign which supported local breast cancer organizations during ... franchise-wide Quack Gives Back initiative, and we’re very pleased with the ...
(Date:12/8/2016)... Pa. (PRWEB) , ... December 08, 2016 , ... ... Medicine Southern Chester County, a Property owned by an affiliate of Seavest, has ... square foot Penn Medicine Southern Chester County ambulatory care center (ACC) was named ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... CURE Media ... centers and advocacy groups, has aligned with Upstage Lung Cancer in efforts to combat ... the announcement, Michael J. Hennessy, Jr said, “CURE Media Group is honored to team ...
(Date:12/8/2016)... ... December 08, 2016 , ... David J. Dykeman , ... Greenberg Traurig, LLP, will speak at DeviceTalks West, Dec. 12, 2016, at the Fairmont ... and attorneys from the firm’s global Life Sciences & Medical Technology Group have been ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... Lilly and Company (NYSE: LLY ) today ... at the 9 th Clinical Trials on Alzheimer,s ... meet the primary endpoint in the EXPEDITION3 clinical trial, ... dementia due to Alzheimer,s disease (AD), and Lilly will ... of mild dementia due to AD. ...
(Date:12/8/2016)... DUBLIN , Dec 8, 2016 Research ... Electrodes Market Analysis and Trends - Adhesion Type, Application, Usability - ... ... The Global Cardiology Electrodes Market is poised to grow at a ... prominent trends that the market is witnessing include advancements in extracellular ...
(Date:12/8/2016)... 8, 2016   TriNetX , the health ... Hospital signed a membership agreement to join ... of new cures. The TriNetX network ... million patients globally, biopharmaceutical companies and contract research ... protocol design, site selection, patient recruitment, and collaborative ...
Breaking Medicine Technology: